Packaging | June 11, 2025
Evertis selects Honeywell Aclar technology to enhance pharmaceutical packaging
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Honeywell Aclar film technology will enable Evertis to develop high-quality barrier packaging solutions
Globally, BRUKINSA is approved in more than 70 countries
Enhanced alignment to better serve customers across the entire drug development lifecycle under the Fujifilm Life Sciences brand umbrella with the tagline Partners for Life
The 16,000-square-foot expansion enhances DuPont’s global sterile operations
AMPLIFY Phase III trial results demonstrated statistically significant and clinically meaningful improvement in progression-free survival for Calquence combinations
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Aumolertinib can be used in patients who have tested positive for a mutation in a gene called epidermal growth factor receptor
BioNTech and Bristol Myers Squibb will jointly execute a broad clinical development program to evaluate and advance BNT327 across numerous solid tumor types
The newly launched protocol will accelerate the clinical development of stenoparib and its drug-specific Drug Response Predictor (DRP) companion diagnostic (CDx) toward potential FDA approval
Subscribe To Our Newsletter & Stay Updated
